Prin­cip­ia, Ab­b­Vie walk away from 2017 part­ner­ship for in­flam­ma­to­ry, au­toim­mune drugs

San Fran­cis­co-based Prin­cip­ia and part­ner Ab­b­Vie have elect­ed to part ways on a col­lab­o­ra­tion they signed about two years ago, which hand­ed the new­ly pub­lic …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER